Feasibility of C2 Monitoring in Korean Renal Transplantation

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3105-3108

  Park, J B ^a   Han, Y S ^a   Kim, S J ^a   Choi, G S ^a   Kwon, C H D ^a   Lee, S K ^a   Kim, D J ^a   Joh, J W ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIPOL; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KOREA; MAJOR CLINICAL STUDY; MALE; MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT;

ADOLESCENT; ADULT; AREA UNDER CURVE; CYCLOSPORINE; DRUG MONITORING; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KOREA; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 37049011605     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.086     Document Type: Article

References (12)

1. Cantarovich M., Besner J.G., Barkun J.S., et al. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transpl 12 (1998) 243
2. Lindholm A., and Kahan B.D. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54 (1993) 205
3. Johnston A., David O.J., and Cooney G.F. Pharmacokinetic validation of Neoral absorption profiling. Transplant Proc 32 (2000) 53S
4. Halloran P.F., Helms L.M., Kung L., et al. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68 (1999) 1356
5. Sindhi R., LaVia M.F., Paulling E., et al. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine + rapamycin regimen. Transplantation 69 (2000) 432
6. Canadian Neoral Renal Transplantation Study Group. Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation. Transplantation 72 (2001) 1024
7. International Neoral Renal Transplantation Study Group. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation. Am J Transplant 2 (2002) 148
8. Clase C.M., Mahalati K., Kiberd B.A., et al. Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling. Am J Transplant 2 (2002) 789
9. Levy G., Thervet E., Lake J., et al. Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation 73 (2002) S12
10. Morris R.G., Russ G.R., Cervelli M.J., et al. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 24 (2002) 479
11. Cole E.H. Neoral monitoring: limitations of trough level monitoring and the potential role of limited sampling strategies. Transplant Proc 32 (2000) 1556
12. Einecke G., Mai I., Fritsche L., et al. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression. Nephrol Dial Transplant 19 (2004) 215